Oral nanomedicine improves cancer immunotherapy by harnessing gut bacterial metabolite
A joint research team—led by professor Young Seok Cho from the School of Medicine, alongside professor James J. Moon from the University of Michigan—has developed the world's first oral, microbiome-based nanomedicine. By leveraging natural metabolites produced by gut bacteria, th
A joint research team—led by professor Young Seok Cho from the School of Medicine, alongside professor James J. Moon from the University of Michigan—has developed the world's first oral, microbiome-based nanomedicine. By leveraging natural metabolites produced by gut bacteria, th This story matters for Science & Discovery readers tracking mech. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. MechNews curates and briefs the science & discovery stories that matter. Our editorial policy →